Kontrol Energy Begins Initial Production Of BioCloud Units

Kontrol Energy Corp (CSE: KNR) has begun the initial production runs of its BioCloud units. The commencement of production was made possible for the company following the news that that National Research Council of Canada Industrial Research Assistance Program would be providing the company with up to $500,000 in funding.

Funding from the NRC is to be used for final commercialization and mass production of its BioCloud technology, with the agency also to provide advisory services to the company. The funding has evidently enabled the company to begin the commercialization phase, with the company concurrently announcing that initial production runs have begun on the COVID-19 detection device.

The initial production runs are anticipated to take five to six weeks, with the first deliveries stated to include the sale of units to distributors and Kontrol customers. Demonstration units are to also be delivered to the Middle East, where pilot customers will receive the units.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Sales are said to be announced when material in nature, while other sales will be reported just in quarterly filing statements.

Kontrol Energy last traded at $2.94 on the CSE.


Information for this briefing was found via Sedar and Kontrol Energy Systems. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold & Copper Stocks Everyone Keeps Asking About | Oct. 12-16 – Weekly Mining Mailbag

Similar Gold Mines Are Valued 10X Higher. Why Not This One? | JW Dumont – Granada Gold Mine

The US Interest Bill Gold Can’t Ignore | Peter Grandich

Recommended

Blue Jay Gold Signs Ocean Partners Deal to Ship Steller Stockpiles Through 2027

Krait Critical Minerals Signs Option for Historical Nevada King Antimony Mine

Related News

Medicago, GSK Report 71% Efficacy Rate From Plant-Based COVID-19 Vaccine Study

Quebec-based biopharmaceutical firm Medicago and healthcare conglomerate GlaxoSmithKline (NYSE: GSK) announce today the results from...

Tuesday, December 7, 2021, 11:21:00 AM

COVID Christmas In China: Crematories Are Overrun As Cases Surge Again

The COVID-19 pandemic is coming full circle as the virus wreaks further havoc in the...

Tuesday, December 27, 2022, 11:20:00 AM

Lite Access Tech Loses Major Customer With Contracts Worth $53 Million

Lite Access Technologies (TSXV: LTE) this afternoon announced that it has lost a major customer...

Friday, December 4, 2020, 02:59:09 PM

Joe Rogan Issues Apology After Spotify Cracks Down on Covid-19 Misinformation

Podcast host Joe Rogan, who is well known for inviting a wide variety of guests—...

Monday, January 31, 2022, 11:38:38 AM

COVID-19 Vaccine Could Force US Dollar Crash, Warns CitiBank

The anticipated distribution of a coronavirus vaccine, coupled with additional monetary easing could spell big...

Sunday, November 22, 2020, 03:59:00 PM